BlackRock's "gift" to BCAT holders is a capital call with a 7% price tag

BlackRock Capital Allocation Term Trust spent one phrase describing its new rights offering to the world: "attractive entry point." The market, which had been paying 12.76% more than the fund's assets were worth just a day earlier, read the fine print, decided the bargain was mostly on BlackRock's side, and knocked the shares down about 7% in a session. The portfolio did nothing wrong. The drop was the premium unwinding — and it was the rational part of the day.

Let both camps read the same paperwork, because rights offerings are where closed-end funds and their shareholders stop being on the same side of the table.

Shared facts: the offer, in plain terms

BCAT is a closed-end fund that runs a blended portfolio of real assets, equities, and fixed income with an income focus. It pays a managed monthly distribution of $0.2542 per share. On the record date of September 25, 2026, every shareholder gets one transferable right for each share held, and five rights buy one new share.

The subscription price is the flashpoint. It is set as 95% of the fund's average market price over the five trading days before the offer's prospectus date, but it is clamped between a floor of 98.5% of net asset value (NAV) and a ceiling of one cent below NAV. Because the shares traded far above NAV, the ceiling does the binding: new shares will likely be priced essentially at NAV — call it around $14 — while the same shares were trading near $15.90. Rights trade on the NYSE as BCAT.RT through late October, and a fully subscribing holder can try to oversubscribe. The offering runs through October 21, BlackRock's adviser pays every expense of it, and the fund promises to hold its current distribution through the end of 2026.

The stated purpose is to raise money to buy "compelling real yields and secular growth themes at an attractive entry point."

Round one: what a rights offering actually is

Start with the shared fact neither camp disputes: BCAT was selling for $15.91 on September 10 while its NAV — the market value of the underlying portfolio divided by shares — was $14.11. That 12.76% premium was a recent fiction of the market, not a fact of the portfolio. The fund's own 52-week average premium is just 0.56%.

A transferable rights offering is a capital call dressed in polite terms. The fund wants more money. It gives existing holders the right to supply it at a fixed discount, and it makes those rights sellable so nobody is forced to participate. Fair enough on its face.

The bear's heaviest punch is arithmetic. New shares are issued at a discount to NAV — the formula allows as little as 98.5% of NAV, never more than one cent below it. Every new share sold below NAV lowers the per-share NAV of everyone who does not bring new money to the table. In a fund trading at a 12.76% premium, the dilution is compounded by the premium itself: the fund gets to plant new shares at roughly book value even though the market values each existing share at a 13% markup. The premium that existing holders paid for is effectively handed to new money at the door.

The bull's answer is that holders are handed the value to offset it. Because rights are transferable, a shareholder who does not want to add cash can sell the rights — the gap between the ~$14 subscription and the ~$15.90 market is real money. A holder who wants to keep their slice intact can subscribe and oversubscribe, buying portfolio exposure at NAV instead of at the premium market. For a fund that trades cheap to its assets only via market mood, that is not a loss; it is the rare chance to acquire assets at book value.

That is the cleanest split in the whole fight, and it scores: the bear wins the "who is dilute" round. The discount and the premium compound on top of each other, and value has to come from somewhere — it comes from holders who neither subscribe nor sell rights. The bull's rights-value offset is real only for the shareholder who does something. Passive holders lose.

Round two: does the capital call signal a problem?

The bear's next move: funds do not run discounted rights offerings from a position of strength. BCAT's distribution is a managed one — the fund sets a monthly payout regardless of earnings — and a yield that high, at over 20% of NAV before this week, is only sustainable if a meaningful slice of it is return of capital rather than income the portfolio actually generated. Raising fresh money at a discount, the bear argues, is how a fund props up that payout while its cushion of undistributed earnings gets thin.

The bull comes back with deployment. The premium that made this offering unattractive also makes it self-funding in a sense: BlackRock is a disciplined, scale-driven asset manager, and a term trust with a fixed horizon that can buy assets at NAV during a window when real yields are "compelling" is doing what it was built to do. The rights let long-term holders grow their position at asset value, the adviser eats the costs rather than the fund, and the distribution stays steady — all conditions that end better than they look.

This round is closer, and the bull half-wins it. A rights offering is not automatically a distress signal; leveraged and managed-distribution CEFs raise capital for deployment all the time. But the bear's point about the payout deserves its own marker: whatever the distribution says, it is managed, and "maintaining the distribution" after an offering is a commitment about cash flows the portfolio has not yet necessarily earned. File it under "watch," not "proof."

Score after two rounds is closer than the first-round rout suggested. The bear holds the arithmetic; the bull holds the deployment story. Which wins is a valuation question, not a narrative one.

The valuation round: what the price had priced in, and now demands

Now make both stories pay rent at the same price. Before the offer, at $15.91 against $14.11 of assets, the stock carried a 12.76% premium — twenty-two times its own 52-week average premium of 0.56%. A premium is a promise the market makes to itself; it is the most fragile line item in a closed-end fund, because it is backed by sentiment and not by a single dollar of portfolio earnings. The rights offering did not create the premium problem. It exposed it.

Here is the decisive arithmetic. The fund is raising new money at ~$14 (roughly NAV) while the market had been willing to pay $15.90 for the same exposure. Any rational new dollar flows in at $14. That supply, available below the market price, pulls the market price toward it. On the announcement day the shares traded down to about $14.80, cutting the premium from 12.76% to roughly 5% at the latest NAV. That is not the market "reacting" hysterically to BlackRock — that is the premium being marked to the reality that a fund can now be bought at asset value. The bear's model, that a premium recognized against a NAV-price issuance cannot survive, is operating exactly as designed.

The reverse-engineering asks what the stock must do now. For the price to justify itself at anything like its former premium, the premium must prove durable against a competitor — its own offering — that sells the identical portfolio at NAV. That is a heavy burden of evidence for a bull to carry, because the fund itself set the new clearing price. The bear wins this round on the size of the gap between premium and history.

Ruling

The verdict separates business from stock. On the business — the portfolio, the deployment, the discipline of buying assets at net asset value during an attractive yield window — the bull is persuasive, and the bear's distress signal is overstated. But on the stock, this was never a portfolio trade; it was a premium trade, and the fund's own paperwork priced the premium away. At $15.91 a share the bull needed a 13% premium to survive the offering intact, and the evidence — a 0.56% historical average, a NAV-priced subscription price, and an immediate 7% markdown — was all on the other side. The bear wins the stock call, and the burden of proof now rests on the premium-holder, not the seller.

The ruling flips on a timestamped tripwire. Watch what happens out of October 21: whether the final subscription price lands at NAV or at the 98.5% floor (a deeper discount means more dilution); whether NAV per share rises as BlackRock deploys the raised capital, which is the only way the dilution is repaid; and whether the premium stays near the day's compressed level or slides back toward the fund's historical 0.56% average — the destination the offering moved it toward. The portfolio has to grow its per-share asset value faster than the newly issued shares dilute it for the bull's deployment story to pay. Until that is visible in the NAV numbers, the cleanest read of this week is unglamorous: the market stopped paying a premium the fund itself had just underpriced.